• Benign Prostatic Hyperplasia
  • Hormone Therapy
  • Genomic Testing
  • Next-Generation Imaging
  • UTUC
  • OAB and Incontinence
  • Genitourinary Cancers
  • Kidney Cancer
  • Men's Health
  • Pediatrics
  • Female Urology
  • Sexual Dysfunction
  • Kidney Stones
  • Urologic Surgery
  • Bladder Cancer
  • Benign Conditions
  • Prostate Cancer

FDA approves 5-day regimen for complicated UTI, acute pyelonephritis

Article

FDA has approved the use of the 5-day, once-daily regimen of levofloxacin (Levaquin), 750 mg IV and oral, for the treatment of complicated urinary tract infections and acute pyelonephritis.

FDA has approved the use of the 5-day, once-daily regimen of levofloxacin (Levaquin), 750 mg IV and oral, for the treatment of complicated urinary tract infections and acute pyelonephritis.

This approval is based on results of a double-blind, randomized clinical trial involving 1,109 patients with either complicated UTI or acute pyelonephritis that assessed the efficacy and safety of levofloxacin versus ciprofloxacin (Cipro), 400/500 mg twice daily for 10 days. Microbiologic eradication and clinical success rates were similar in both treatment groups, demonstrating the resolution of, or improvement in, urinary symptoms for both the 5- and 10-day regimens.

"The availability of this high-dose, short-course antibiotic regimen provides clinicians with an important tool in the management of complicated UTI and acute pyelonephritis," said Richard David, MD, of the David Geffen School of Medicine at UCLA. "Patients do not always finish a longer course of antibiotics. A shorter course of antibiotic offers patients the convenience of 5-day, once-daily therapy."

Related Videos
Michael S. Cookson, MD, MMHC, FACS, answers a question during a Zoom video interview
David Barquin, MD, answers a question during a Zoom video interview
Alexandra Tabakin, MD, answers a question during a Zoom video interview
Blurred interior of hospital |  Image Credit: © jakkapan - stock.adobe.com
Laura Bukavina, MD, MPH, answers a question during a Zoom video interview
Image of kidneys | Image Credit: © peterschreiber.media - stock.adobe.com
Related Content
© 2024 MJH Life Sciences

All rights reserved.